Solasonine

Solasonine is a steroidal glycoalkaloid found in nightshade plants that modulates cytoskeletal proteins including cofilin-related protein 1A (COR1A) and thymosin beta-4. Research shows potential anticancer activity through cytoskeletal disruption, though evidence remains limited to laboratory studies.

Category: Compound Evidence: 4/10 Tier: Preliminary (in-vitro/animal)
Solasonine — Hermetica Encyclopedia

Origin & History

Solasonine is a steroidal glycoalkaloid derived from solasodine, found primarily in Solanum plants of the Solanaceae family (nightshades), including eggplants and black nightshade. It consists of solasodine bound to a three-sugar unit (solatriose) and is extracted from plant tissue through standard phytochemical isolation methods.

Historical & Cultural Context

The provided research does not contain information about solasonine's historical use in traditional medicine systems. While sources discuss it as a naturally occurring plant alkaloid in Solanaceae species, traditional medical applications and cultural contexts are not addressed.

Health Benefits

• Potential cytoskeletal modulation through targeting cofilin-related proteins (COR1A) and thymosin beta-4 (TYB4) - preliminary in vitro evidence only
• Possible applications in pharmacology and cancer treatment noted in research - specific mechanisms not detailed
• Note: No human clinical trials available in the provided research
• Safety concerns outweigh benefits at high doses - classified as poisonous at elevated levels
• Natural occurrence in foods suggests dietary exposure at low levels - eggplants contain 0.17-1 mg/100g

How It Works

Solasonine targets cytoskeletal regulatory proteins, specifically cofilin-related protein 1A (COR1A) and thymosin beta-4 (TYB4), which control actin filament dynamics in cells. This cytoskeletal modulation may disrupt cancer cell migration and proliferation pathways. The compound's steroidal glycoalkaloid structure allows membrane interaction and cellular penetration to affect these intracellular targets.

Scientific Research

The provided research contains no human clinical trials, randomized controlled trials, or meta-analyses evaluating solasonine as a therapeutic agent. Available literature focuses on analytical chemistry measuring solasonine content in eggplant varieties and in vitro mechanistic studies examining cytoskeletal protein interactions.

Clinical Summary

Current evidence for solasonine consists entirely of preliminary in vitro laboratory studies examining its effects on isolated cells and proteins. No human clinical trials have been conducted to establish safety, efficacy, or appropriate dosing in humans. Animal studies and pharmacokinetic data are also lacking in published literature. The existing research focuses primarily on mechanistic understanding rather than therapeutic applications, making clinical relevance uncertain.

Nutritional Profile

Solasonine is a steroidal glycoalkaloid found in Solanum species including eggplant and black nightshade; it consists of the steroidal aglycone solanidine conjugated to the trisaccharide chacotriose, and exerts biological effects by disrupting cholesterol-dependent cell membrane integrity and inhibiting acetylcholinesterase, classifying it as a bioactive secondary metabolite rather than a nutritional compound.

Preparation & Dosage

No clinically studied dosage ranges are available. Natural food sources contain: Solanum macrocarpon fruits 16-23 mg/100g, common eggplant (Solanum melongena) 0.17-1 mg/100g wet basis. Without human clinical trials, therapeutic dosing cannot be established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

α-solamargine, solasodine, α-solanine, α-chaconine

Safety & Interactions

As a glycoalkaloid from nightshade plants, solasonine may share toxicity profiles with related compounds like solanine, potentially causing gastrointestinal upset, neurological symptoms, or hemolysis at high doses. No specific drug interactions have been documented, but the compound's effects on cellular proteins suggest potential interference with cancer medications or cytoskeletal-targeting drugs. Pregnant and breastfeeding women should avoid solasonine due to unknown safety profiles. Individuals with nightshade sensitivities may be at increased risk for adverse reactions.